# SEG Drug HTML Closure Status

**Document ID:** `SEG_DRUG_HTML_CLOSURE_STATUS`  
**Mode:** `CONTROLLED CONTENT GOVERNANCE EXECUTION`  
**Review pathway:** `OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY`  
**Source:** Drug HTML  
**Ownership:** `SEG_INTERNAL_ASSET` for the declared retained artifact scope  
**Current gate:** `BLOCKED_PENDING_EVIDENCE`  
**Owner-review decision:** `OWNER_REQUIRES_FURTHER_REVIEW`

## 1. Closure boundary

This status record documents the available artifact evidence, the completed internal metadata definition, the supported structural field observations, and the remaining clinical and governance requirements. It does not certify drug safety, clinical relevance, completeness, currency, rights, provenance, or source approval. The HTML artifact remains unchanged.

## 2. Locked artifact and internal version identity

| Field | Value | Status |
|---|---|---|
| Artifact ID | `LOCAL_INTAKE_ARTIFACT` | `CONFIRMED` |
| Artifact reference | `/home/ubuntu/upload/deepseek_html_20260615_a3266b.html` | `CONFIRMED` |
| Artifact size | 25,918 bytes | `CONFIRMED` |
| Artifact line count | 394 lines | `CONFIRMED` |
| SHA-256 | `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac` | `CONFIRMED` |
| Internal retained-representation version ID | `SEG-P0-DRUG-HTML-LOCAL-INTAKE-001` | `CONFIRMED` as internal governance identifier |
| Canonical source version/edition | `NOT_AVAILABLE` | Blocking |
| Internal version owner | Dr. Alaa Al-Asfar — SEG Medical Content Owner; Emergency Medicine Physician; Project Lead | `CONFIRMED` from ownership declaration |
| Internal version meaning | Identifier for this retained SEG artifact representation; not a source publication version or creation-date assertion | `CONFIRMED` as governance convention |
| Known creation/recovery date | `NOT_SUPPLIED` | Not inferred |

The internal identifier does not replace canonical source/version evidence and must not be interpreted as an external edition, publication date, or clinical currency claim.[1] [2]

## 3. Complete internal metadata definition

The following fields form the internal metadata definition for controlled review. Values are recorded only where supplied or supported by the retained evidence.

| Internal metadata field | Current value | Status |
|---|---|---|
| `source_id` | `LOCAL_INTAKE_ARTIFACT` | `CONFIRMED` |
| `artifact_version_id` | `SEG-P0-DRUG-HTML-LOCAL-INTAKE-001` | `CONFIRMED` internal identifier |
| `artifact_sha256` | `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac` | `CONFIRMED` |
| `artifact_locator` | Local retained path listed above | `CONFIRMED` |
| `content_owner` | Dr. Alaa Al-Asfar | `CONFIRMED` by explicit project declaration |
| `ownership_type` | `SEG_INTERNAL_ASSET` | `CONFIRMED` for declared scope |
| `canonical_title` | `NOT_AVAILABLE` | `NOT_AVAILABLE` |
| `publisher/custodian` | `NOT_AVAILABLE` | `NOT_AVAILABLE` |
| `source_version/edition` | `NOT_AVAILABLE` | `NOT_AVAILABLE` |
| `source_publication/update_date` | `NOT_AVAILABLE` | `NOT_AVAILABLE` |
| `original_locator` | `NOT_AVAILABLE` | `NOT_AVAILABLE` |
| `language` | Arabic/English labels observed in artifact; canonical language metadata not closed | `PARTIALLY_CONFIRMED` |
| `professional_track` | `NOT_SUPPLIED`; not inferred from topic or filename | `NOT_AVAILABLE` |
| `taxonomy_id/version` | `NOT_AVAILABLE` | `NOT_AVAILABLE` |
| `intended_audience` | Healthcare professionals and medical learners | `CONFIRMED` by internal ownership policy |
| `usage_scope` | Educational and professional training; controlled project access | `CONFIRMED` by internal ownership policy |
| `public_distribution` | Not authorized by current policy | `CONFIRMED` policy control |
| `external_redistribution` | Not authorized by current policy | `CONFIRMED` policy control |
| `provenance/extraction_lineage` | `NOT_AVAILABLE` | Blocking |
| `rights/display_scope` | `NOT_AVAILABLE` | Blocking |
| `review_state` | `OWNER_REVIEW_BLOCKED` | `CONFIRMED` observed governance state |
| `approval_state` | `NOT_APPROVED` | `CONFIRMED` observed governance control |
| `audit_linkage` | P0-AUD-001 through P0-AUD-015 are recorded; source-specific clinical decision remains open | `PARTIALLY_CONFIRMED` |

This metadata definition is an internal governance record, not a Content Record or import mapping. No database, schema, Zod, Prisma, or SQL record was created.

## 4. Available Drug HTML fields

Read-only structural evidence records the following available fields and containers. They are retained as observations and do not establish clinical validity.

| Available field/container | Observed evidence | Status |
|---|---|---|
| `summaryData` sections | 19 observed | `CONFIRMED` structurally |
| `quick` entries | 21 observed | `CONFIRMED` structurally |
| `drugList` entities | 47 observed | `CONFIRMED` structurally |
| `trapsList` entries | 20 observed | `CONFIRMED` structurally |
| Embedded JavaScript/data arrays | Observed | `PARTIALLY_CONFIRMED` as structure |
| Arabic/English clinical labels | Observed | `PARTIALLY_CONFIRMED` as presentation |
| Explicit pairwise interaction table | Not observed in available artifact evidence | `NOT_ESTABLISHED`; not evidence of absence |
| Entity-to-source/version locators | Not closed | `INCOMPLETE` |

## 5. Missing clinical fields and required owner validation

The following fields require review at entity and section level. Their status is `NOT_ESTABLISHED`, not a clinical finding that the information is absent.

| Clinical field group | Required validation |
|---|---|
| Drug identity | Active ingredient, aliases, formulation, concentration, route, and disambiguation |
| Emergency relevance | Indication, emergency context, intended population, exclusions, and scope |
| Dose/administration | Dose, units, route, frequency, timing, maximums, adjustments, and instructions |
| Contraindications/precautions | Contraindications, allergies, population limits, organ-function cautions, and high-risk warnings |
| Interactions | Drug-drug, drug-disease, duplicate therapy, and interaction references |
| Adverse effects/monitoring | Material adverse effects, toxicity, monitoring, escalation, and follow-up |
| Safety/currency | Current reference/protocol alignment, safety notices, version/date, and citations |
| Traceability | Exact entity/section/source locators and review/audit linkage |

The owner medical validation record is prepared as `SEG_DRUG_HTML_OWNER_REVIEW_RECORD.md` and remains `OWNER_REVIEW_BLOCKED`. It documents the review scope and evidence boundary but contains no completed clinical or Pharmacology/Drug Safety decision.[3]

## 6. Resolved and remaining evidence

| Evidence area | Current state |
|---|---|
| Retained artifact identity and hash | Closed at retained-artifact level |
| Internal ownership and intended use | Declared for the retained scope |
| Internal version identifier | Assigned for governance tracking; canonical source version remains open |
| Structural field inventory | Documented as non-clinical evidence |
| Canonical source/title/publisher/version/date/locator | Remaining blocker |
| Provenance and extraction history | Remaining blocker |
| Rights/display/redistribution scope | Remaining blocker |
| Clinical and drug-safety validation | Remaining blocker |
| Metadata/track/taxonomy closure | Remaining blocker |
| Technical HTML/lineage review | Remaining blocker |
| Source-level approval | Not granted |

## 7. Current gate and next action

**Current gate:** `BLOCKED_PENDING_EVIDENCE`  
**Next allowed action:** Assemble the source/version, provenance, rights, metadata, and review evidence packet; then complete separate owner-governed Emergency Medicine, Pharmacology/Drug Safety, metadata, technical, rights, provenance, and audit reviews against `SEG-P0-DRUG-HTML-LOCAL-INTAKE-001` and the locked SHA-256.

No medication fact, dose, interaction, contraindication, or safety statement may be corrected or created through this status record. No source may be set to `READY_FOR_NORMALIZATION`.

## 8. Controls

```text
APPROVED_SOURCES = NONE
NORMALIZATION = BLOCKED_PENDING_APPROVED_SOURCE
READY_FOR_NORMALIZATION = NOT_SET
SOURCE_REGISTRY_APPROVAL_STATES = UNCHANGED
CONTENT_MODIFIED = FALSE
```

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_P0_VERSION_CONTROL_REGISTER.md "SEG P0 Version Control Register"

[2]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_BLOCKER_RESOLUTION_REPORT.md "SEG Drug HTML Blocker Resolution Report"

[3]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_OWNER_REVIEW_RECORD.md "SEG Drug HTML Owner Review Record"

[4]: file:///home/ubuntu/seg-internship-output/SEG_OWNER_REVIEW_AUTHORITY_POLICY.md "SEG Owner Review Authority Policy"

[5]: file:///home/ubuntu/seg-internship-output/SEG_P0_AUDIT_TRAIL_REGISTER.md "SEG P0 Audit Trail Register"

**Document status:** `DRUG_HTML_CLOSURE_STATUS_RECORDED_EVIDENCE_INCOMPLETE`
